Articles by Amy Ritter, PhD - BioPharm International

ADVERTISEMENT

ADVERTISEMENT

Articles by Amy Ritter, PhD

Federal Appeals Court Lifts Ban on Funding for Embryonic Stem Cell Research

May 10, 2011

On Apr. 29, 2011, a federal appeals court has lifted a ban on federal funding for embryonic stem cell (ESC) research. The move was celebrated by researchers hoping to use such cells for research, but it is likely that the decision will be appealed. Embryonic stem cells are pluripotent cells derived from embryonic tissue in a process that usually results in the destruction of the embryo. The ban on funding did not apply to stem cells derived from adult tissue.

IMS: Growth in Drugs Stalls, Generic Use Up

May 3, 2011

The IMS institute has released its report on the use of medicines in the United States during 2010. The report looks at consumer spending on prescription drugs, and presents data on how many prescriptions have been filled, in which therapeutic areas, and compares use of generics with branded drugs.

A Record Number of Therapies for Cancer Currently in Development

Apr 19, 2011

A Record Number of Therapies for Cancer Currently in Development

Nigeria Looks to Simple Packaging Controls and International Cooperation to Curb Counterfeit Drugs

Apr 12, 2011

Nigeria Looks to Simple Packaging Controls and International Cooperation to Curb Counterfeit Drugs

New Challenges for Use of Embryonic Stem Cells

Apr 5, 2011

New Challenges for Use of Embryonic Stem Cells

Johnson & Johnson Acquires Vaccine Developer Crucell

Mar 8, 2011

Johnson and Johnson Acquires Vaccine Developer Crucell

ADVERTISEMENT

ADVERTISEMENT

Click here